Dermatology Doctors in St Louis, MO Accepting Medicare

6 Dermatology doctors found. Showing 1 - 6

Lester Thomas Reese, MD Dermatology Medicare: Medicare Enrolled Practice Location: 522 North New Ballas Road, Suite 316, St Louis, MO 63141 Phone: 314-567-5873    Fax: 314-567-4040

Madhavi Kandula, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 845 North New Ballas Court, Suite 310, St Louis, MO 63141 Phone: 314-692-0221    Fax: 314-692-0686

Natalie L Semchyshyn, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1755 S Grand, St Louis, MO 63104 Phone: 314-256-3400

Joseph Duvall, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1755 S Grand, St Louis, MO 63104 Phone: 314-256-3433    Fax: 214-256-3431

Stacy Beaty, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1755 S Grand, St Louis, MO 63104 Phone: 314-256-3433    Fax: 314-256-3431

Ms. Madeliene Elaine Gainers, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 660 S. Euclid Avenue, Washington Univ Med Ctr/div Of Dermatology, St Louis, MO 63110 Phone: 314-454-8622    Fax: 314-454-5928

News Archive

Tumor-killing virus selectively targets diseased brain cells

New findings show that a specialized virus with the ability to reproduce its tumor-killing genes can selectively target tumors in the brains of mice and eliminate them.

Novel method for going back to memories shows promise in treatment of depression

A randomized controlled trial that has appeared in the current issue of Psychotherapy and Psychosomatics indicates that a new method for going back to memories may be of help in depression.

arGEN-X's alliance with Lilly highlights potential of SIMPLE Antibody platform

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced it has entered into an alliance with Eli Lilly and Company ("Lilly") to discover and develop novel therapeutic antibody products against targets submitted by Lilly.

Biothera enhances innate immune responses to Imprime PGG drug candidate

Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.

Read more Medical News

› Verified 2 days ago